The teratogenic risk of antiepileptic drug polytherapy

Grants

Funding Acknowledgements

We wish to acknowledge the support of our colleagues, medical and nonmedical, for referring patients and increasing patient awareness of the register. We thank the Scientific Advisory Board and the Ethical Research Committees of St Vincent's Hoptal, Monash Medical Centre and the Royal Melbourne Hospital, and other institutions. We are indebted for support from the Epilepsy Society of Australia, The Victorian Epilepsy Foundation, Epilepsy Australia, and generous financial support from the pharmaceutical industry, including Sanofi-Synthelabo, UCB Pharma, Janssen Cilag, Novartis, and Pfizer, as well as past support from Glaxo.Disclosure: None of the authors has any conflict of interest to disclose.